Evolutionary history of the Clostridium difficile pathogenicity locus

Genome Biology and Evolution

Volumn 6, Issue 1, 2014, Pages 36-52

  Dingle, Kate E ^a,b   Elliott, Briony ^c,d   Robinson, Esther ^e   Griffiths, David ^a,b   Eyre, David W ^a,b   Stoesser, Nicole ^a,b   Vaughan, Alison ^a,b   Golubchik, Tanya ^f   Fawley, Warren N ^g,h   Wilcox, Mark H ^g,h   Peto, Timothy E ^a,b   Walker, A Sarah ^a,b   Riley, Thomas V ^c,d   Crook, Derrick W ^a,b   Didelot, Xavier ⁱ  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d PATHWEST LABORATORY MEDICINE   (Australia)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g LEEDS GENERAL INFIRMARY   (United Kingdom)

^h UNIVERSITY OF LEEDS   (United Kingdom)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bacterial evolution; Clostridium difficile; Mobile genetic element; Pa Loc; Pathogenicity locus; Toxin

Indexed keywords

TOXIN;

ARTICLE; BACTERIAL EVOLUTION; BACTERIAL GENE; CLOSTRIDIUM DIFFICILE; GENE LOCUS; GENETICS; HOMOLOGOUS RECOMBINATION; MOBILE GENETIC ELEMENT; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PALOC; PATHOGENICITY; PATHOGENICITY LOCUS; PHYLOGENY; TRANSPOSON; VIRULENCE;

BACTERIAL EVOLUTION; CLOSTRIDIUM DIFFICILE; MOBILE GENETIC ELEMENT; PALOC; PATHOGENICITY LOCUS; TOXIN;

BASE SEQUENCE; CLOSTRIDIUM DIFFICILE; DNA TRANSPOSABLE ELEMENTS; EVOLUTION, MOLECULAR; GENES, BACTERIAL; GENETIC LOCI; HOMOLOGOUS RECOMBINATION; MOLECULAR SEQUENCE DATA; PHYLOGENY; VIRULENCE;

EID: 84892524901     PISSN: None     EISSN: 17596653     Source Type: Journal    
DOI: 10.1093/gbe/evt204     Document Type: Article

References (69)

1. Adams V, Lyras D, Farrow KA, Rood JI. 2002. The clostridial mobilisable transposons. Cell Mol Life Sci. 59:2033-2043.
2. Bakker D, Smits WK, Kuijper EJ, Corver J. 2012. TcdC does not significantly repress toxin expression in Clostridium difficile 630ΛErm. PLoS One 7: e43247.
3. Bauer MP, et al. 2011. Clostridium difficile infection in Europe: a hospitalbased survey. Lancet 377:63-73.
4. Bentley DR, et al. 2008. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456:53-59.
5. Braun V, Hundsberger T, Leukel P, Sauerborn M, Von EichelStreiber C. 1996. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 27:29-38.
6. Cartman ST, Kelly ML, Heeg D, Heap JT, Minton NP. 2012. Precise manipulation of the Clostridium difficile chromosome reveals a lack of association between the tcdC genotype and toxin production. Appl Environ Microbiol. 78:4683-4690.
7. Carver T, Thomson N, Bleasby A, Berriman M, Parkhill J. 2009. DNAPlotter: circular and linear interactive genome visualization. Bioinformatics 25: 119-120.
8. Carver TJ, et al. 2005. ACT: the Artemis Comparison Tool. Bioinformatics 21:3422-3423.
9. Chaves-Olarte E, et al. 1999. A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins. J Biol Chem. 274:11046-11052.
10. Chun J, et al. 2009. Comparative genomics reveals mechanism for shortterm and long-term clonal transitions in pandemic Vibrio cholerae. Proc Natl Acad Sci U S A. 106:15442-15447.
11. Cornaglia G, Giamarellou H, Rossolini GM. 2011. Metallo-b-lactamases: a last frontier for b-lactams? Lancet Infect Dis. 11:381-393.
12. Davies AH, Roberts AK, Shone CC, Acharya KR. 2011. Super toxins from a super bug: structure and function of Clostridium difficile toxins. Biochem. J. 436:517-526.
13. Deshpande A, et al. 2013. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother. 68:1951-1961.
14. Didelot X, Falush D. 2007. Inference of bacterial microevolution using multilocus sequence data. Genetics 175:1251-1266.
15. Didelot X, et al. 2012. Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol. 1312: R118.
16. Dingle KE, et al. 2011. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One 6:e19993.
17. Dingle KE, et al. 2012. Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large scale whole genome sequencing. J Infect Dis. 207:675-686.
18. Elliott B, Reed R, Chang BJ, Riley TV. 2009. Bacteremia with a large clostridial toxin-negative, binary toxin-positive strain of Clostridium difficile. Anaerobe 15:249-251.
19. Enright MC, et al. 2002. The evolutionary history of methicillin- resistant Staphylococcus aureus MRSA. Proc Natl Acad Sci U S A. 99: 7687-7692.
20. Flannagan SE, Zitzow LA, Su YA, Clewell DB. 1994. Nucleotide sequence of the 18kb conjugative transposon Tn916 from Enterococcus faecalis. Plasmid 32:350-354.
21. Forsberg KJ, et al. 2012. The shared antibiotic resistome of soil bacteria and human pathogens. Science 337:1107-1111.
22. Govind R, Vediyappan G, Rolfe RD, Dupuy B, Fralick JA. 2009. Bacteriophage-mediated toxin gene regulation in Clostridium difficile. J Virol. 83:12037-12045.
23. Green GA, Schue V, Monteil H. 1995. Cloning and characterization of the cytotoxin L-encoding gene of Clostridium sordellii: homology with Clostridium difficile cytotoxin B. Gene 161:57-61.
24. Griffiths D, et al. 2010. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol. 48:770-778.
25. Gruber AR, Lorenz R, Bernhart SH, Neuböck R, Hofacker IL. 2008. The Vienna RNA websuite. Nucleic Acids Res. 36:W70-W74.
26. Guindon S, et al. 2010. New algorithms and methods to estimate maximum- likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 59:307-321.
27. Hammond GA, Johnson JL. 1995. The toxigenic element of Clostridium difficile strain VPI 10463. Microb Pathog. 19:203-213.
28. He M, et al. 2010. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A. 107:7527-7532.
29. He M, et al. 2013. Emergence and global spread of epidemic healthcareassociated Clostridium difficile. Nat Genet. 45:109-113.
30. Ho SY, Shapiro B, Phillips MJ, Cooper A, Drummond AJ. 2007. Evidence for time dependency of molecular rate estimates. Syst Biol. 56: 515-522.
31. Hundsberger T, et al. 1997. Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem. 244: 735-742.
32. Johnson S, et al. 1999. Epidemics of diarrhea caused by a clindamycinresistant strain of Clostridium difficile in four hospitals. N Engl J Med. 341:1645-1651.
33. Jolley KA, Maiden MC. 2010. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11:595.
34. Just I, Gerhard R. 2004. Large clostridial cytotoxins. Rev Physiol Biochem Pharmacol. 152:23-47.
35. Karas JA, Enoch DA, Aliyu SH. 2010. A review of mortality due to Clostridium difficile infection. J Infect. 61:1-8.
36. Kato H, et al. 1999. Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett. 175:197-203.
37. Kelly CP. 2012. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect. 18(Suppl 6):21-27.
38. Knetsch CW, et al. 2012. Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages. Infect Genet Evol. 12: 1577-1585.
39. Knetsch CW, et al. 2013. Current application and future perspectives of molecular typingmethods to study Clostridium difficile infections. Euro Surveill. 18:20381.
40. Kuehne SA, et al. 2010. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711-713.
41. Kurtz S, et al. 2004. Versatile and open software for comparing large genomes. Genome Biol. 5:R12.
42. Leach DR. 1994. Long DNA palindromes, cruciform structures, genetic instability and secondary structure repair. Bioessays 16: 893-900.
43. Loo VG, et al. 2005. A predominantly clonalmulti-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 353:2442-2449.
44. Luo C, Walk ST, Gordon DM, Feldgarden M, Tiedje JM. 2011. Genome sequencing of environmental Escherichia coli expands understanding of the ecology and speciation of the model bacterial species. Proc Natl Acad Sci U S A. 108:7200-7205.
45. Mani N, Dupuy B. 2001. Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci U S A. 98:5844-5849.
46. Matamouros S, England P, Dupuy B. 2007. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol. 64:1274-1288.
47. McDonald LC, et al. 2005. An epidemic, toxin gene variant strain of Clostridium difficile. N Engl J Med. 353:2433-2441.
48. Miller M, et al. 2010. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis. 50: 194-201.
49. Morelli G, et al. 2010. Microevolution of Helicobacter pylori during prolonged infection of single hosts and within families. PLoS Genet. 6: e1001036.
50. Paradis E, Claude J, Strimmer K. 2004. APE: Analyses of phylogenetics and evolution in R language. Bioinformatics 20:289-290.
51. Piddock LJ. 2006. Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol. 4:629-636.
52. Roberts AP, Mullany P. 2009. A modular master on the move: the Tn916 family of mobile genetic elements. Trends Microbiol. 17: 251-258.
53. Rutherford K, et al. 2000. Artemis: sequence visualization and annotation. Bioinformatics 16:944-945.
54. Sambol SP, Merrigan MM, Lyerly D, Gerding DN, Johnson S. 2000. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease. Infect Immun. 68:5480-5487.
55. Sebaihia M, et al. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet. 38:779-786.
56. Shen J, Wang Y, Schwarz S. 2013. Presence and dissemination of the multiresistance gene cfr in Gram-positive and Gram-negative bacteria. J Antimicrob Chemother. 68:1697-1706.
57. Sievers F, et al. 2011. Fast, scalable generation of high quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 7: 539.
58. Soehn F, et al. 1998. Genetic rearrangements in the pathogenicity locus of Clostridium difficile strain 8864 - implications for transcription, expression and enzymatic activity of toxins A and B. Mol Gen Genet. 258: 222-232.
59. Spigaglia P, Barbanti F, Mastrantonio P. 2011. Multidrug resistance in European Clostridium difficile clinical isolates. J Antimicrob Chemother. 66:2227-2234.
60. Stabler RA, Dawson LF, Phua LT,Wren BW. 2008. Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene tcdB sequences. J Med Microbiol. 57:771-775.
61. Stabler RA, et al. 2012. Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS One 7: e31559.
62. Stoesser N, et al. 2011. Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-associated infection. J Clin Microbiol. 49: 3994-3996.
63. Tamura K, et al. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 28: 2731-2739.
64. Tan K, Wee B, Song K. 2001. Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile. J Med Microbiol. 50: 613-619.
65. Tenover FC, Tickler IA, Persing DH. 2012. Antimicrobial-resistant strains of Clostridium difficile from North America. Antimicrob Agents Chemother. 56:2929-2932.
66. Walk ST, et al. 2011. Non-toxigenic Clostridium sordellii: clinical and microbiological features of a case of cholangitis-associated bacteremia. Anaerobe 17:252-256.
67. Walker AS, et al. 2013. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis. 56:1589-1600.
68. Wellington EM, et al. 2013. The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria. Lancet Infect Dis. 13:155-165.
69. Zerbino DR, Birney E. 2008. Velvet: algorithms for de-novo short read assembly using de Bruijn graphs. Genome Res. 18: 821-829.